The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion

Y. H. Kim, H. S. Lee, J. S. Choi, J. O. Na, K. H. Seo, H. G. Hwang (Republic Of Korea)

Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Session: Extrapulmonary tuberculosis
Session type: Thematic Poster Session
Number: 3058
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. H. Kim, H. S. Lee, J. S. Choi, J. O. Na, K. H. Seo, H. G. Hwang (Republic Of Korea). The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion. Eur Respir J 2010; 36: Suppl. 54, 3058

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Diagnostic value of quantitative measurement of pleural fluid interferon-gamma (IFN–gamma) versus QuantiFERON-TB Gold in tube assays (QFT-IT) in blood, pleural fluid and isolated pleural fluid cells in tuberculous pleural effusion
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Using a whole-blood interferon-gamma assay to improve diagnosis of tuberculous pleural effusion
Source: Eur Respir J 2010; 36: 679-681
Year: 2010



Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Clinical utility of pleural fluid interferon-gamma release assay in tuberculous pleurisy diagnosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017

Performance of a commercial whole blood interferon-gamma release assays in the management of pleural effusions
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

T-cell interferon-γ release assay for the diagnosis of tuberculous pleuritis in routine clinical practice
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007



The value of interferon (IFN)-γ pleural effusion tests in diagnosis of tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Diagnostic accuracy of pleural fluid adenosine deaminase in patients with tuberculous pleural effusion while keeping pleural biopsy as a gold standard
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Variability of the sensitivity of three tests for the diagnosis of pleural TB according to the findings in pleural tissue
Source: Eur Respir J 2005; 26: Suppl. 49, 241s
Year: 2005

Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

The diagnostic value of pleural fluid IL - 8 level in parapeneumonic effusion and patients with empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 440s
Year: 2002

Bactec versus histopathology in the clinical diagnosis of tuberculous pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 472s
Year: 2001

Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis
Source: Eur Respir J 2009; 34: 1118-1126
Year: 2009



Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110
Year: 2002

Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004

Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Diagnostic values of pleural, γ-IFN and IL 2 levels in tuberculosis pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 141s
Year: 2006